The Affiliated Hospital of Guangdong Medical College
Welcome,         Profile    Billing    Logout  
 3 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zhao, Bin
NCT04275323: Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-1)

Completed
3
302
RoW
NL003, HGF plasmid, pCK-HGF-X7, Normal Saline, Placebo
Beijing Northland Biotech. Co., Ltd.
Arterial Occlusive Disease, Ischemia, Ulcers, Peripheral Vascular Disease
06/24
06/24
NL003-CLI-III-2, NCT04274049: Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia

Completed
3
242
RoW
NL003, HGF plasmid, pCK-HGF-X7, Normal Saline, Placebo
Beijing Northland Biotech. Co., Ltd.
Arterial Occlusive Disease, Ischemia, Ulcers, Peripheral Vascular Disease
12/23
12/23
TQ-A3334-II-03, NCT06706310: Evaluate TQ-A3334 Combined Nucleoside (Acid) Analogs in the First Treatment/Treatment of Chronic HBV Infection

Recruiting
2
116
RoW
Placebo, TQA3334 Tablet, Nucleoside (acid) analogs (NAs)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chronic Hepatitis B
12/25
06/26
Luo, Hai-Qing
2021-FXY-452, NCT05211232: Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma

Active, not recruiting
3
450
RoW
Tislelizumab, BGB-A317, Placebo
Sun Yat-sen University, Cancer Hospital of Guizhou Province, Hunan Cancer Hospital, Wuzhou Red Cross Hospital, Affiliated Hospital of Guangdong Medical University
Nasopharyngeal Carcinoma
05/26
05/28

Download Options